Competitor News, Government/Regulatory

FoundationOne®Liquid CDx Receives FDA-Approval as a Companion Diagnostic for EXKIVITY® (mobocertinib) to Identify Patients with EGFR Exon 20 Insertion Mutations in Advanced Non-Small Cell Lung Cancer

Posted on

May 04, 2023 07:01 AM Eastern Daylight Time CAMBRIDGE, Mass.–(BUSINESS WIRE)–Foundation Medicine, Inc., a leader in molecular profiling for cancer, today announced that it has received approval from the U.S. Food and Drug Administration (FDA) for FoundationOne®Liquid CDx to be used as a companion diagnostic for EXKIVITY® (mobocertinib), which is currently…

Blogs/Publications, Competitor News, Events, Marketing

PicnicHealth Announces the Presentation of Three Abstracts at ISPOR Annual Meeting Highlighting the Utility of Real-World Evidence in Understanding Health Care Utilization in Neurology

Posted on

Poster presentations to include insights on paths toward diagnosis and disease modifying therapies in patients facing Myasthenia Gravis, Alzheimer’s Disease, and Multiple Sclerosis May 03, 2023 09:00 AM Eastern Daylight Time SAN FRANCISCO–(BUSINESS WIRE)–PicnicHealth, a patient-centered health technology company, today announced the presentation of three abstracts to be presented at…

Blogs/Publications, Competitor News, Events, Marketing

Flatiron Health Research Highlights Power of Real-World Oncology Data at ISPOR 2023

Posted on

May 03, 2023 10:30 AM Eastern Daylight Time NEW YORK–(BUSINESS WIRE)–Flatiron Health is pleased to announce their presence at ISPOR—The Professional Society for Health Economics and Outcomes Research 2023 Conference, held in Boston this May. A total of ten on-stage presentations and six research posters being presented at the conference…

Competitor News, Product Updates

Inspire Launches Patient-Centered Real-World Evidence, Including Innovative Data and Analytic Solutions

Posted on

ARLINGTON, VA / ACCESSWIRE / May 3, 2023 / Inspire, the leading patient engagement platform, announced today the launch of its Real-World Evidence (RWE) solutions. Inspire RWE will provide innovative data and analytic solutions to help biopharmaceutical, medical device, and life sciences companies gather patient-centered real-world insights to drive better patient…

Awards, Competitor News, Marketing

MDClone Receives Third Straight “Best Healthcare Big Data Platform” Award From MedTech Breakthrough

Posted on

Prestigious international annual awards program recognizes standout digital health & medical technology products and companies BE’ER SHEVA, Israel, May 3, 2023 /PRNewswire/ — MDClone, a leading data analytics and synthetic data company, today announced that it has been named “Best Healthcare Big Data Platform” for the third consecutive year in the 7th annual MedTech Breakthrough Awards program…

Collaborations, Competitor News, Data Partnership

Lynx.MD Partners with Prometheus Laboratories and Gastro Health to Leverage Medical Data Intelligence Platform for Inflammatory Bowel Disease Research

Posted on

PALO ALTO, CA / ACCESSWIRE / May 2, 2023 / Lynx.MD, a leading medical data intelligence platform, today announced a new partnership with Prometheus Laboratories Inc. (“Prometheus”) and Gastro Health to securely unite real-world clinical data for retrospective analysis of inflammatory bowel disease (IBD) biologic treatment. The partnership will bring together…

Competitor News, Government/Regulatory, Product Updates

Tempus Receives U.S. FDA Approval for xT CDx, a NGS-Based In Vitro Diagnostic Device

Posted on

May 01, 2023 08:00 AM Eastern Daylight Time CHICAGO–(BUSINESS WIRE)–Tempus, a leader in artificial intelligence and precision medicine, today announced that the U.S. Food and Drug Administration (FDA) has approved the company’s first Premarket Approval (PMA) application for its companion diagnostic test, xT CDx. xT CDx is a 648-gene next-generation sequencing…

Clinical Trials, Collaborations, Competitor News, Data Partnership, Pharma

Flatiron Health Embarks on Strategic Collaboration with Sanofi to Make Clinical Trials More Efficient by Streamlining Data Acquisition at the Point of Care

Posted on

May 01, 2023 09:00 AM Eastern Daylight Time NEW YORK–(BUSINESS WIRE)–Flatiron Healthannounced a new collaboration today with Sanofi in their pursuit to redesign the clinical trial experience for sponsors, sites, and patients in the therapeutic area of oncology. The multi-study collaboration between Sanofi and Flatiron will focus on improving clinical trial data…

AI, Competitor News, Product Updates

ConcertAI’s TeraRecon Adds the Releases of an AI-Assisted Clinical Suite Solution, Neuro Suite to Provide Comprehensive Solutions for Neurological Disorders

Posted on

CAMBRIDGE, Mass., April 28, 2023 /PRNewswire/ — ConcertAI’s TeraRecon, the advanced visualization and clinical AI SaaS category leader, has announced the release of its AI-driven clinical suite, Neuro Suite. Purpose-built for disease triage, differential diagnostic insights, and care activation in many neurological disease states such as neuro-oncology, dementia, multiple sclerosis, and more,…